• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Correspondence
Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"
Hyung Seok Kim1, Soon Sun Kim2, Jae Youn Cheong2, Jung Woo Eun2
1Department of Biochemistry, Kosin University College of Medicine; Seo-gu, Busan 49267, Republic of Korea
2Department of Gastroenterology, Ajou University School of Medicine; 164 Worldcup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea
Correspondence :  Jung Woo Eun ,
Tel: 82-31-219-4681, Fax: 82-31-219-4680, Email: jetaimebin@gmail.com
Received: March 12, 2025   Accepted: March 15, 2025
KeyWords: Liver cancer; GULP1; Recurrence; Metastasis; Biomarker
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 298 View
  • 22 Download
Related articles

Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”

GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 701
TOTAL : 2629732
Close layer